Richard E Uihlein is of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 10.3 Million shares of GALT, which is worth approximately $25.7 Million. The most recent transaction as insider was on Jan 24, 2024, when has been sold 23,256 shares (Common Stock) at a price of $1.72 per share, resulting in proceeds of $40,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.3M
0% 3M change
0.32% 12M change
Total Value Held $25.7 Million

Richard E Uihlein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2024
BUY
Grant, award, or other acquisition
$40,000 $1.72 p/Share
23,256 Added 0.23%
10,268,751 Common Stock
Sep 26 2023
BUY
Exercise of conversion of derivative security
$8,609,385 $3.85 p/Share
2,236,204 Added 17.93%
10,235,495 Common Stock
Jan 26 2023
BUY
Grant, award, or other acquisition
$39,999 $1.11 p/Share
36,036 Added 0.45%
7,999,291 Common Stock
Jan 24 2022
BUY
Grant, award, or other acquisition
$35,000 $1.98 p/Share
17,677 Added 0.22%
7,936,677 Common Stock
REU

Richard E Uihlein

Norcross, GA

Track Institutional and Insider Activities on GALT

Follow GALECTIN THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT